《新股消息》微創機器人(02252.HK)公開超購逾162倍 一手中籤率3.3%
自微創醫療(00853.HK)分拆並擬於主板上市的微創機器人(02252.HK)公布招股結果,於全球發售3,620萬股H股,原計劃本港公開發售部份佔10%,由於香港公開發售錄得超額認購約162.83倍,經重新分配將公開發售股份上調至全球發售項下初步可供認購發售股份總數的50%。國際發售項下初步提呈已獲大幅超額認購,約為國際發售項下初
步可供認購H股總數約16倍以上。
每股發售價定為43.2元,為招股價上限定價(原每股招股價介乎36元至43.2元),認購一手500股的中籤率為3.3%。該股將於周二(2日)掛牌。
微創機器人料是次上市淨集約14.57億元,當中35%擬用於其核心產品圖邁,21%用於其骨科手術機器人,19%用於其他候選產品,5%用於擴建其產能及增強供應鏈管理能力,10%用於取得創新的機器人技術及產品擴張其產品組合,10%用於營運資金及一般公司用途。
基石投資者已認購1,629萬股,當中Aspex認購342.95萬股,Hillhouse Funds、LAV、Snow Lake Funds and Accounts及Yorkool分別認購257.2萬股。而聯席保薦人、聯席全球協調人、聯席帳簿管理人及聯席牽頭經辦人為摩根大通及中金公司,聯席牽頭經辦人為富途證券及利弗莫爾證券。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.